All Stories

  1. Jacareubin Derivatives Increase Their Anti-Allergic Activity
  2. Cobalamin Metabolism Is a Key Process of Breast Cancer Cells That Offers New Ways for Diagnosis and Treatment
  3. Design and Semisynthesis of Aminocannabinoids as Neurological Magic Shotguns
  4. Dillapiole Dampens the Expression of the Major Virulence Genes of Francisella tularensis
  5. Cardio-pulmonary arrest in a patient revived with naloxone following reported use of 7-hydroxymitragynine
  6. From Kratom to Semi‐Synthetic Opioids: The Rise and Risks of MGM‐15
  7. Uncaria attenuata and its main corynanthean alkaloid, villocarine A, exert antinociceptive effects in rats via activation of central μ-opioid receptors
  8. Effects of kratom alkaloids on mesolimbic dopamine release
  9. Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets
  10. The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α2 receptor activity in vitro and in vivo
  11. Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones
  12. Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine
  13. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
  14. The Polypharmacological Effects of Cannabidiol
  15. Natural Corynanthe-Type Cholinesterase Inhibitors from Malaysian Uncaria attenuata Korth.: Isolation, Characterization, In Vitro and In Silico Studies
  16. Directed Biosynthesis of Mitragynine Stereoisomers
  17. Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer
  18. Interactive Effects of µ-Opioid and Adrenergic-α2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
  19. Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects
  20. Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
  21. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
  22. The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study
  23. Plant growth and phytoactive alkaloid synthesis in Mitragyna speciosa (kratom) in response to varying radiance
  24. Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors
  25. Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors
  26. Correction to “Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery”
  27. Structure–Activity Relationships of the Antimalarial Agent Artemisinin 10. Synthesis and Antimalarial Activity of Enantiomers of rac-5β-Hydroxy-d-Secoartemisinin and Analogs: Implications Regarding the Mechanism of Action
  28. Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery
  29. Assessment of Contribution of 7‐Hydroxymitragynine and Mitragynine Pseudoindoxyl to the MU‐Opioid Activity of Mitragynine
  30. Mitragynine Attenuates the Development of Tolerance to and Withdrawal from Morphine in Rats
  31. Pharmacological Characterization of Mitragynine: Antinociception, Respiratory Depression, Self‐Administration, Drug Discrimination, Tolerance, and withdrawal in Rats
  32. Serotonin 5‐HT 1A Receptor Activity of Kratom Alkaloids Mitragynine, Paynantheine, and Speciogynine
  33. The Lofexidine‐Like Discriminative Effects of the Primary Kratom Alkaloid Mitragynine in Rats
  34. Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine
  35. Coumarins and other constituents from Deverra battandieri
  36. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Rats
  37. Exploring the Chemistry of Alkaloids from Malaysian Mitragyna speciosa (Kratom) and the Role of Oxindoles on Human Opioid Receptors
  38. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
  39. Proposed Mechanism for the Antitrypanosomal Activity of Quercetin and Myricetin Isolated from Hypericum afrum Lam.: Phytochemistry, In Vitro Testing and Modeling Studies
  40. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method
  41. Kratom (Mitragyna speciosa Korth.): A description on the ethnobotany, alkaloid chemistry, and neuropharmacology
  42. Chlorinated Guaiane-Type Sesquiterpene Lactones as Cytotoxic Agents against Human Tumor Cells
  43. Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
  44. Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
  45. Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
  46. Evaluation of the rewarding effects of mitragynine and 7‐hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats
  47. Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy
  48. Pharmacokinetics and Safety of Mitragynine in Beagle Dogs
  49. Characterization of Chemical Compounds and Antioxidant Activity of Centaurea solstitialis sp. schouwii (DC.) Q. et S. (Asteraceae)
  50. 3-O-Formyl -27-Hydroxyfusidic Acid: A New Metabolite of Fusidic Acid by Cunninghamella echinulata
  51. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
  52. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
  53. Bioanalytical method development and validation of corynantheidine, a kratom alkaloid, using UPLC-MS/MS, and its application to preclinical pharmacokinetic studies
  54. Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids
  55. Total Phenolic and Flavonoid Content and Biological Activities of Extracts and Isolated Compounds of Cytisus villosus Pourr.
  56. Perspective on the Therapeutics of Anti-Snake Venom
  57. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats
  58. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra‐performance liquid chromatography−tandem mass spectrometry
  59. Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia
  60. Computationally aided stereochemical assignment of undescribed bisabolenes from Calea urticifolia
  61. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)
  62. Centaurea microcarpa Coss. & Dur. (Asteraceae) extracts: New cyanogenic glucoside and other constituents
  63. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats
  64. Humulene derivatives from Saharian Asteriscus graveolens
  65. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine
  66. Secondary metabolites from two Hispaniola Ageratina species and their cytotoxic activity
  67. 3′-Hydroxy-3,4′-dimethoxyflavone-induced cell death in human leukaemia cells is dependent on caspases and reactive oxygen species and attenuated by the inhibition of JNK/SAPK
  68. Isolation, Antioxidant and Antimicrobial Activities of Ecdysteroids from Serratula cichoracea
  69. Secondary metabolites from the aerial parts of Cytisus villosus Pourr.
  70. Evaluation of triazole and isoxazole derivatives as potential anti-infective agents
  71. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants
  72. 3′-Hydroxy-3,4′-dimethoxyflavone blocks tubulin polymerization and is a potent apoptotic inducer in human SK-MEL-1 melanoma cells
  73. Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 Inhibitor
  74. Interactions of Desmethoxyyangonin, a Secondary Metabolite fromRenealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B
  75. Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B
  76. Components and antioxidant, anti-inflammatory, anti-ulcer and antinociceptive activities of the endemic species Stachys mialhesi de Noé
  77. Sesquiterpenoids Isolated from Two Species of the Asteriscus Alliance
  78. Secondary Metabolites, Evaluation of the DPPH Free-Radical Scavenging Effect by Electron Spin Resonance and Antibacterial Activity of the Endemic Species Stachys circinata
  79. Secondary Metabolites and Antioxidant Activity of Limonium duriusculum (de Girard) Kuntze Extracts
  80. In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower
  81. Secondary Metabolites from Linaria tingitana
  82. In vitro opioid receptor displacement affinity and in vitro behavioral studies by tetrad assay of Nelumbo nucifera flower
  83. Isolation of acacetin from Calea urticifolia as a potent inhibitor of human monoamine oxidase-A and B
  84. Isolation, chemical profiling, and standardization of betaine, choline, acetylcholine, and 20-hydroxyecdysone from Atriplex species
  85. Secondary metabolites isolated from Salvia bogotensis
  86. Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors
  87. Antinociceptive activity of extracts and secondary metabolites from wild growing and micropropagated plants of Renealmia alpinia
  88. Phytochemistry of Mitragyna speciosa
  89. Cannabinoid and opioid radioligand displacement by secondary metabolites from Banisteriopsis caapi
  90. Investigation of Nelumbo nucifera flower for human opioid receptor displacement affinity
  91. Phenolic compounds, antioxidant activity and ultrastructural study from Protea hybrid ‘Susara’
  92. Flavanones from Miconia prasina
  93. Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  94. Fatty Acids with in Vitro Binding Affinity for Human Opioid Receptors from the Fungus Emericella nidulans
  95. Correction to Neocosmospora sp.-Derived Resorcylic Acid Lactones with in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  96. A chemotaxonomic study of endemic species of genus Tanacetum from the Canary Islands
  97. New strategy toward the diverted synthesis of oxidized abietane diterpenes via oxidation of 6,7-dehydroferruginol methyl ether with dimethyldioxirane
  98. Neocosmospora sp.-Derived Resorcylic Acid Lactones with in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  99. A New Flavonoid C-Glycoside from Solanum elaeagnifolium with Hepatoprotective and Curative Activities against Paracetamol- Induced Liver Injury in Mice
  100. A New Flavonoid C-Glycoside from Solanum elaeagnifolium with Hepatoprotective and Curative Activities against Paracetamol-Induced Liver Injury in Mice
  101. Ayanin diacetate-induced cell death is amplified by TRAIL in human leukemia cells
  102. Secondary Metabolites from Two Species of Tolpis and Their Biological Activities
  103. Cell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signaling
  104. Cytotoxic sesquiterpene lactones and other constituents of Centaurea omphalotricha
  105. A new flavonoid and other constituents fromCentaurea nicaeensisAll. var.wallianaM.
  106. Phytochemical study of Halimium halimifolium
  107. Antifungal Metabolites from the Roots of Diospyros virginiana by Overpressure Layer Chromatography
  108. Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens
  109. Secondary Metabolites from Two Species of Pulicaria and Their Cytotoxic Activity
  110. Benzyl Derivatives within VitroBinding Affinity for Human Opioid and Cannabinoid Receptors from the FungusEurotium repens
  111. Flavonoid aglycones and sterol from Chrysanthemum fontanesii
  112. Flavonoid aglycones from Centaurea maroccana
  113. Chemotaxonomy of Gonospermum and related genera
  114. Four flavonoids from the aerial part of Ononis angustissima species
  115. A flavonoid with cytotoxic activity and other constituents from Centaurea africana
  116. Sesquiterpene Lactones fromGonospermum gomeraeandG. fruticosumand Their Cytotoxic Activities
  117. Mycophenolic Derivatives fromEupenicilliumparvum
  118. Induction of G2-M phase arrest and apoptosis by α-methylene-γ-butyrolactones in human leukemia cells
  119. A new guaianolide and other constituents from Achillea ligustica
  120. Synthesis of novel spirostanic saponins and their cytotoxic activity
  121. The Presence of Capsule in Cryptococcus neoformans Influences the Gene Expression Profile in Dendritic Cells during Interaction with the Fungus
  122. A New Ceramide fromSuillus luteus and Its Cytotoxic Activity against Human Melanoma Cells
  123. Sesquiterpene lactones and other constituents from Matricaria chamomilla L.
  124. Revisiting the Reaction Between Diaminomaleonitrile and Aromatic Aldehydes: a Green Chemistry Approach
  125. Synthesis and antiproliferative activity of novel sugiol β-amino alcohol analogs
  126. Isolation, Structure Elucidation, Total Synthesis, and Evaluation of New Natural and Synthetic Ceramides on Human SK-MEL-1 Melanoma Cells
  127. A Homo-Isoflavonoid and a Cytotoxic Saponin fromDracaena draco
  128. A new guaianolide and other sesquiterpene lactones from Centaurea acaulis L. (Asteraceae)
  129. Sesquiterpenoids fromPulicariacanariensisand Their Cytotoxic Activities#
  130. Cladocalol, a pentacyclic 28-nor-triterpene from Eucalyptus cladocalyx with cytotoxic activity
  131. Lanostanoid Triterpenes fromLaetiporussulphureusand Apoptosis Induction on HL-60 Human Myeloid Leukemia Cells
  132. Icogenin, a new cytotoxic steroidal saponin isolated from Dracaena draco
  133. Isolation fromEucalyptusoccidentalisand Identification of a New Kaempferol Derivative that Induces Apoptosis in Human Myeloid Leukemia Cells
  134. Flavans of dragon’s blood from Dracaena draco and Dracaena tamaranae
  135. Novel Cytostatic Lanostanoid Triterpenes fromGanoderma australe
  136. Sesquiterpenoid Derivatives fromGonospermumelegansand Their Cytotoxic Activity for HL-60 Human Promyelocytic Cells#
  137. Synthesis and Antiproliferative Activity of a New Compound Containing an α-Methylene-γ-Lactone Group
  138. New Lanostanoids from the FungusGanodermaconcinna
  139. A facile chemoselective deacetylation in the presence of benzoyl and p-bromobenzoyl groups using p-toluenesulfonic acid
  140. Phenolic Compounds of Dragon's Blood fromDracaenadraco
  141. Synthesis of 2t-Substituted-1r,3c-BIS(2′-Hydroxy-5-Substituted-Benzyl)-Imidazolidines by Reaction of 1,3-BIS(2′-Hydroxy-5′-Substituted-Benzyl)-Imidazolidines with Aromatic Aldehydes
  142. Lanostanoid Triterpenes fromGanodermalucidum